Rhythm Biosciences Limited (RHY.AX)
AUD 0.08
(-3.53%)
AUD 0.08
(-3.53%)
| Breakdown | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -6.13 Million | -6.95 Million | -6.21 Million | -5.4 Million | -2.74 Million | -2.94 Million |
| Net Income | -6.85 Million | -8.21 Million | -6.31 Million | -6.61 Million | -4.02 Million | -2.54 Million |
| Depreciation & Amortization | 198.66 Thousand | 189.37 Thousand | 101.48 Thousand | 146.64 Thousand | 141.28 Thousand | 65.36 Thousand |
| Deferred income taxes | - | -3 Million | -2.6 Million | -558.22 Thousand | -18.59 Thousand | -94.75 Thousand |
| Stock-based compensation | -1.04 Million | 3 Million | 2.6 Million | 558.22 Thousand | 18.59 Thousand | 94.75 Thousand |
| Change in working capital | 1.56 Million | -1.93 Million | -410.03 Thousand | 504.79 Thousand | 1.03 Million | -555.55 Thousand |
| Other non-cash items | -2.00 | 3 Million | 410.03 Thousand | 558.21 Thousand | 100.95 Thousand | 94.75 Thousand |
| Investing Cash Flow | -82.28 Thousand | -99.12 Thousand | -27 Thousand | -68.27 Thousand | -45.53 Thousand | -110.26 Thousand |
| Investments in PPE | -82.28 Thousand | -99.12 Thousand | -27 Thousand | -68.27 Thousand | -45.53 Thousand | -110.26 Thousand |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | - | - | - | - | - | - |
| Financing Cash Flow | 2.8 Million | 3.63 Million | 11.84 Million | 5.9 Million | -142.22 Thousand | - |
| Debt repayment | -92.72 Thousand | -85.53 Thousand | -7656.00 | -42.43 Thousand | -82.36 Thousand | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | -24.21 Thousand | -467.85 Thousand | -225.12 Thousand | - | - |
| Common Stock Issuance | 2.89 Million | 3.74 Million | 12.32 Million | 6.16 Million | - | - |
| Other Financing Activities | 2.89 Million | -85.53 Thousand | -7656.00 | -42.43 Thousand | -59.86 Thousand | - |
| Accounts receivables | -1.03 Million | 16.9 Thousand | 70.99 Thousand | -40.19 Thousand | 658.52 Thousand | -762.46 Thousand |
| Accounts payables | -1.06 Million | 891.9 Thousand | -552.32 Thousand | 505.92 Thousand | 361.82 Thousand | 164.12 Thousand |
| Inventory | 2.76 Million | -2.76 Million | - | - | - | - |
| Other working capital | -162.91 Thousand | -75.49 Thousand | 71.28 Thousand | 39.07 Thousand | 17.79 Thousand | 42.78 Thousand |
| Cash at beginning of period | 4.12 Million | 7.55 Million | 2.22 Million | 1.79 Million | 4.72 Million | 7.78 Million |
| Cash at end of period | 709.49 Thousand | 4.12 Million | 7.55 Million | 2.22 Million | 1.79 Million | 4.72 Million |
| Capital Expenditure | -82.28 Thousand | -99.12 Thousand | -27 Thousand | -68.27 Thousand | -45.53 Thousand | -110.26 Thousand |
| Effect of forex changes on cash | - | - | -281.69 Thousand | - | - | - |
| Net cash flow / Change in cash | -3.41 Million | -3.42 Million | 5.32 Million | 430.43 Thousand | -2.93 Million | -3.05 Million |
| Free Cash Flow | -6.21 Million | -7.05 Million | -6.24 Million | -5.47 Million | -2.78 Million | -3.05 Million |
| Breakdown | 2024 FY | 2024 Q4 | 2024 Q2 | 2023 FY | 2023 Q4 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -6.85 Million | -2.76 Million | -4.09 Million | -8.21 Million | -4.53 Million | -3.67 Million |
| Depreciation & Amortization | 198.66 Thousand | 96.07 Thousand | 102.58 Thousand | 189.37 Thousand | 96.18 Thousand | 93.19 Thousand |
| Deferred income taxes | - | - | - | -3 Million | 646.29 Thousand | - |
| Stock-based compensation | - | -237.96 Thousand | -810.05 Thousand | 3 Million | 1.09 Million | 1.9 Million |
| Change in working capital | 1.56 Million | 1.56 Million | - | -1.93 Million | -1.93 Million | - |
| Other non-cash items | -2.38 Million | -1.74 Million | 1.14 Million | 3 Million | -522.15 Thousand | 1.97 Million |
| Investing Cash Flow | -82.28 Thousand | -1595.00 | -80.68 Thousand | -99.12 Thousand | -43.96 Thousand | -55.16 Thousand |
| Investments in PPE | -82.28 Thousand | -1595.00 | -80.68 Thousand | -99.12 Thousand | -43.96 Thousand | -55.16 Thousand |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | - | - | - | - | - | - |
| Financing Cash Flow | 2.8 Million | 2.58 Million | 224.33 Thousand | 3.63 Million | 475 Thousand | 3.15 Million |
| Debt repayment | - | - | -45.67 Thousand | -85.53 Thousand | - | -42.12 Thousand |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | -24.21 Thousand | - | - |
| Common Stock Issuance | 2.89 Million | 2.62 Million | 270 Thousand | 3.74 Million | 518.41 Thousand | 3.19 Million |
| Other Financing Activities | - | 2.58 Million | 270 Thousand | -85.53 Thousand | 475 Thousand | 3.19 Million |
| Accounts receivables | 28.31 Thousand | -1.03 Million | - | 16.9 Thousand | 908.8 Thousand | - |
| Accounts payables | -1.06 Million | - | - | 891.9 Thousand | - | - |
| Inventory | 2.76 Million | 2.76 Million | - | -2.76 Million | -2.76 Million | - |
| Other working capital | -162.91 Thousand | -162.91 Thousand | - | -75.49 Thousand | -75.49 Thousand | - |
| Cash at beginning of period | 4.12 Million | 1.21 Million | 4.12 Million | 7.55 Million | 8.84 Million | 7.55 Million |
| Cash at end of period | 709.49 Thousand | 709.49 Thousand | 1.21 Million | 4.12 Million | 4.12 Million | 8.84 Million |
| Capital Expenditure | -82.28 Thousand | -1595.00 | -80.68 Thousand | -99.12 Thousand | -43.96 Thousand | -55.16 Thousand |
| Effect of forex changes on cash | - | - | 4.12 Million | - | -4.12 Million | 7.55 Million |
| Net cash flow / Change in cash | -3.41 Million | -508.49 Thousand | -2.9 Million | -3.42 Million | -4.72 Million | 1.29 Million |
| Free Cash Flow | -6.21 Million | -3.08 Million | -3.13 Million | -7.05 Million | -5.2 Million | -1.85 Million |
PYRAMID
SMAG
GIANLIFE
CPS
002184
GNL